: Efficacy and Safety of Tofacitinib in Patients With Active Ankylosing Spondylitis (AS)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
Category & Conditions: Immune System Diseases and Conditions
Medicine: XELJANZ®(TOFACITINIB)
ClinicalTrials.gov Identifier (NCT): NCT03502616
Protocol ID: A3921120
PrintDownloadOpen Plain Language Summary Result: Click here